A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Applying to Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) · New York, New York
Answer a few short questions to share with the research team.